Affigen

Affigen

Affigen

Affigen develops tumoridentifying therapies to treat cancer.
Founded
2016
Raised
$17M
Follow us
Alexa global traffic share
21 Feb 2017
$17,000,000
Venture capital (Series A)
Black Beret Life Sciences

Affigen Closes $17m Series A Financing

FinSMEs